Brian Corvese - 13 Oct 2021 Form 3 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
/s/ Christine Klaskin, attorney-in-fact
Issuer symbol
INKT
Transactions as of
13 Oct 2021
Transactions value $
$0
Form type
3
Filing time
20 Oct 2021, 19:05:17 UTC
Previous filing
21 Jun 2021
Next filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INKT Common Stock 278K 13 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INKT Stock Option (Right to Buy) 13 Oct 2021 Common Stock 27.8K $0.02 Direct F1
holding INKT Stock Option (Right to Buy) 13 Oct 2021 Common Stock 209K $0.01 Direct F2
holding INKT Stock Option (Right to Buy) 13 Oct 2021 Common Stock 139K $3.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an option to purchase shares of the common stock, which vests in three equal annual installments beginning on November 19, 2019.
F2 Represents an option to purchase shares of our common stock, which vested as to 33% of the underlying shares on January 30, 2021, and with respect to the remainder, in eight equal quarterly installments thereafter, in each case, generally subject to continued employment.
F3 Represents an option to purchase shares of the common stock, which vests fully on February 11, 2022.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney